These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 28628854)

  • 1. Prevalence and predictors of HCV among a cohort of opioid treatment patients in Dar es Salaam, Tanzania.
    Lambdin BH; Lorvick J; Mbwambo JK; Rwegasha J; Hassan S; Lum P; Kral AH
    Int J Drug Policy; 2017 Jul; 45():64-69. PubMed ID: 28628854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV/HCV co-infection and associated risk factors among injecting drug users in Dar es Salaam, Tanzania: potential for HCV elimination.
    Leyna GH; Makyao N; Mwijage A; Ramadhan A; Likindikoki S; Mizinduko M; Leshabari MT; Moen K; Mmbaga EJ
    Harm Reduct J; 2019 Dec; 16(1):68. PubMed ID: 31829199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The hepatitis C cascade of care in people who inject drugs in Dar es Salaam, Tanzania.
    Mohamed Z; Rwegasha J; Kim JU; Shimakawa Y; Poiteau L; Chevaliez S; Bhagani S; Taylor-Robinson SD; Thursz MR; Mbwambo J; Lemoine M
    J Viral Hepat; 2018 Dec; 25(12):1438-1445. PubMed ID: 29974582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methadone treatment for HIV prevention-feasibility, retention, and predictors of attrition in Dar es Salaam, Tanzania: a retrospective cohort study.
    Lambdin BH; Masao F; Chang O; Kaduri P; Mbwambo J; Magimba A; Sabuni N; Bruce RD
    Clin Infect Dis; 2014 Sep; 59(5):735-42. PubMed ID: 24855149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generating trust: Programmatic strategies to reach women who inject drugs with harm reduction services in Dar es Salaam, Tanzania.
    Zamudio-Haas S; Mahenge B; Saleem H; Mbwambo J; Lambdin BH
    Int J Drug Policy; 2016 Apr; 30():43-51. PubMed ID: 26880500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modelling the impact of HIV and HCV prevention and treatment interventions for people who inject drugs in Dar es Salaam, Tanzania.
    Fraser H; Stone J; Wisse E; Sambu V; Mfisi P; Duran IJ; Soriano MA; Walker JG; Makere N; Luhmann N; Kafura W; Nouvellet M; Ragi A; Mundia B; Vickerman P
    J Int AIDS Soc; 2021 Oct; 24(10):e25817. PubMed ID: 34661964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Convenience without disclosure: a formative research study of a proposed integrated methadone and antiretroviral therapy service delivery model in Dar es Salaam, Tanzania.
    Cooke A; Saleem H; Mushi D; Mbwambo J; Hassan S; Lambdin BH
    Addict Sci Clin Pract; 2017 Oct; 12(1):23. PubMed ID: 29041950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating the Integrated Methadone and Anti-Retroviral Therapy Strategy in Tanzania Using the RE-AIM Framework.
    Hassan S; Cooke A; Saleem H; Mushi D; Mbwambo J; Lambdin BH
    Int J Environ Res Public Health; 2019 Feb; 16(5):. PubMed ID: 30823440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upscaling prevention, testing and treatment to control hepatitis C as a public health threat in Dar es Salaam, Tanzania: A cost-effectiveness model.
    Scott N; Mohamed Z; Rwegasha J; Mbwambo J; Lemoine M; Hellard M
    Int J Drug Policy; 2021 Feb; 88():102634. PubMed ID: 31882272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Understanding hepatitis B, hepatitis C and HIV among people who inject drugs in South Africa: findings from a three-city cross-sectional survey.
    Scheibe A; Young K; Moses L; Basson RL; Versfeld A; Spearman CW; Sonderup MW; Prabdial-Sing N; Manamela J; Puren AJ; Rebe K; Hausler H
    Harm Reduct J; 2019 Apr; 16(1):28. PubMed ID: 30975139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C virus seroprevalence among patients enrolled at the opioid substitution therapy center in Bihar: A cross-sectional study.
    Kumar A; Mahajan H; Chaturvedi S; Kumar A; Kumar S; Sahoo GC; Das VNR; Pandey K
    PLoS One; 2023; 18(6):e0287333. PubMed ID: 37319276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and risk factors associated with HIV-1 infection among people who inject drugs in Dar es Salaam, Tanzania: a sign of successful intervention?
    Likindikoki SL; Mmbaga EJ; Leyna GH; Moen K; Makyao N; Mizinduko M; Mwijage AI; Faini D; Leshabari MT; Meyrowitsch DW
    Harm Reduct J; 2020 Mar; 17(1):18. PubMed ID: 32209110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HCV serostatus and injection sharing practices among those who obtain syringes from pharmacies and directly and indirectly from syringe services programs in rural New England.
    Romo E; Rudolph AE; Stopka TJ; Wang B; Jesdale BM; Friedmann PD
    Addict Sci Clin Pract; 2023 Jan; 18(1):2. PubMed ID: 36597153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age-Related Differences in Past or Present Hepatitis C Virus Infection Among People Who Inject Drugs: National Human Immunodeficiency Virus Behavioral Surveillance, 8 US Cities, 2015.
    Abara WE; Trujillo L; Broz D; Finlayson T; Teshale E; Paz-Bailey G; Glick S; Al-Tayyib AA; Robinson WT; Masiello-Schuette S; Sey EK; Anderson BJ; Poe J; Braunstein S
    J Infect Dis; 2019 Jul; 220(3):377-385. PubMed ID: 30915477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost effectiveness of simplified HCV screening-and-treatment interventions for people who inject drugs in Dar-es-Salaam, Tanzania.
    Mohamed Z; Scott N; Nayagam S; Rwegasha J; Mbwambo J; Thursz MR; Brown AS; Hellard M; Lemoine M
    Int J Drug Policy; 2022 Jan; 99():103458. PubMed ID: 34624732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlates of health care seeking behaviour among people who inject drugs in Dar es Salaam, Tanzania.
    Mlunde LB; Sunguya BF; Mbwambo JK; Ubuguyu OS; Shibanuma A; Yasuoka J; Jimba M
    Int J Drug Policy; 2016 Apr; 30():66-73. PubMed ID: 26821555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implementation and Operational Research: Linkage to Care Among Methadone Clients Living With HIV in Dar es Salaam, Tanzania.
    Tran OC; Bruce RD; Masao F; Ubuguyu O; Sabuni N; Mbwambo J; Lambdin BH
    J Acquir Immune Defic Syndr; 2015 Jun; 69(2):e43-8. PubMed ID: 26009835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High prevalence of human immunodeficiency virus, hepatitis B and C viral infections among people who inject drugs: a potential stumbling block in the control of HIV and viral hepatitis in Tanzania.
    Kawambwa RH; Majigo MV; Mohamed AA; Matee MI
    BMC Public Health; 2020 Feb; 20(1):177. PubMed ID: 32019536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An urgent need to scale-up injecting drug harm reduction services in Tanzania: prevalence of blood-borne viruses among drug users in Temeke District, Dar-es-Salaam, 2011.
    Bowring AL; Luhmann N; Pont S; Debaulieu C; Derozier S; Asouab F; Toufik A; van Gemert C; Dietze P; Stoove M
    Int J Drug Policy; 2013 Jan; 24(1):78-81. PubMed ID: 23036650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of and risk factors for hepatitis C virus antibody among people who inject drugs in Cambodia: a national biological and behavioral survey.
    Yi S; Mun P; Chhoun P; Chann N; Tuot S; Mburu G
    Harm Reduct J; 2019 Apr; 16(1):29. PubMed ID: 31036011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.